Effect of metabolic syndrome on prognosis in patients with peripheral T-cell lymphoma
MetS is an independent prognostic factor for both OS and PFS of PTCL patients, showing strong prognostic effect. Combining MetS with IPI enables further stratification of patients, and MetS can strongly supplement the existing prognostic scoring systems in the future.
Authors
- Liru Li (ORCID: https://orcid.org/0000-0002-4597-2802)
- Yue Zhang (ORCID: https://orcid.org/0000-0003-2286-8866)
- Rongli Sun (ORCID: https://orcid.org/0000-0003-1694-5319)
- Han Zhang (ORCID: https://orcid.org/0000-0001-9522-4418)
- Hongbin Li (ORCID: https://orcid.org/0000-0001-7688-7718)
- Shu Zhao
- Qingyuan Zhang (ORCID: https://orcid.org/0000-0002-6794-1660)
- Wenhui Zhao (ORCID: https://orcid.org/0000-0002-0497-0085)
- Shiqi Gao (ORCID: https://orcid.org/0000-0003-1572-7715)
- Mingzhe Yang
Institutions
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Hematology
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1080/16078454.2025.2591516
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00